Osaic Holdings’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25K Sell
1
-35
-97% -$1.66K ﹤0.01% 7194
2025
Q4
$540 Buy
36
+35
+3,500% +$1.79K ﹤0.01% 7426
2025
Q3
$183 Hold
1
﹤0.01% 7702
2025
Q2
$700 Hold
1
﹤0.01% 7273
2025
Q1
$975 Sell
1
-75
-99% -$6.19K ﹤0.01% 6823
2024
Q4
$90K Buy
76
+69
+986% +$7.46K ﹤0.01% 4263
2024
Q3
$5.29K Buy
7
+1
+17% +$133 ﹤0.01% 6162
2024
Q2
$12.2K Sell
6
-1
-14% -$133 ﹤0.01% 5663
2024
Q1
$10.8K Buy
7
+6
+600% +$714 ﹤0.01% 5706
2023
Q4
$3.61K Buy
+1
New +$99 ﹤0.01% 6299

Other funds holding NVO

Osaic Holdings's NVO Position: Q1 2026 in Review

Osaic Holdings increased its Novo Nordisk (NVO) stake by 14% in Q1 2026, buying an estimated $2.04M and bringing the position to 342,477 shares worth $12.6M. The position accounts for 0.02% of the portfolio, ranked #774.

Osaic Holdings first reported a position in NVO in Q1 2020 and has held it in 25 quarters since. The position peaked at $58.7M in Q3 2023. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Osaic Holdings held 342,477 shares of Novo Nordisk worth $12.6M as of Q1 2026.
  • Osaic Holdings bought 43,148 Novo Nordisk shares in Q1 2026, an estimated $2.04M.
  • Novo Nordisk made up 0.02% of Osaic Holdings's portfolio in Q1 2026, its #774 holding.
  • Osaic Holdings first reported a position in Novo Nordisk in Q1 2020 and has held it in 25 quarters since.
  • Osaic Holdings's Novo Nordisk position peaked at $58.7M in Q3 2023.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.